6CJZ
| |
5AGT
| Crystal structure of the LeuRS editing domain of Mycobacterium tuberculosis in complex with the adduct (S)-3-(Aminomethyl)-4-chloro-7-ethoxybenzo[c][1,2]oxaborol-1(3H)-ol-AMP | 分子名称: | 4-Chloro-3-aminomethyl-7-[ethoxy]-3H-benzo[C][1,2]oxaborol-1-ol modified adenosine, GLYCEROL, LEUCINE--TRNA LIGASE, ... | 著者 | Palencia, A, Li, X, Alley, M.R.K, Ding, C, Easom, E.E, Hernandez, V, Meewan, M, Mohan, M, Rock, F.L, Franzblau, S.G, Wang, Y, Lenaerts, A.J, Parish, T, Cooper, C.B, Waters, M.G, Ma, Z, Mendoza, A, Barros, D, Cusack, S, Plattner, J.J. | 登録日 | 2015-02-03 | 公開日 | 2016-03-02 | 最終更新日 | 2024-01-10 | 実験手法 | X-RAY DIFFRACTION (1.45 Å) | 主引用文献 | Discovery of Novel Oral Protein Synthesis Inhibitors of Mycobacterium Tuberculosis that Target Leucyl-tRNA Synthetase. Antimicrob.Agents Chemother., 60, 2016
|
|
5AGS
| Crystal structure of the LeuRS editing domain of Mycobacterium tuberculosis in complex with the adduct 3-(Aminomethyl)-4-bromo-7-ethoxybenzo[c][1,2]oxaborol-1(3H)-ol-AMP | 分子名称: | 3-(AMINOMETHYL)-4-BROMO-7-ETHOXYBENZO[C][1,2]OXABOROL-1(3H)-OL-MODIFIED ADENOSINE, LEUCYL-TRNA SYNTHETASE, METHIONINE | 著者 | Palencia, A, Li, X, Alley, M.R.K, Ding, C, Easom, E.E, Hernandez, V, Meewan, M, Mohan, M, Rock, F.L, Franzblau, S.G, Wang, Y, Lenaerts, A.J, Parish, T, Cooper, C.B, Waters, M.G, Ma, Z, Mendoza, A, Barros, D, Cusack, S, Plattner, J.J. | 登録日 | 2015-02-03 | 公開日 | 2016-03-09 | 最終更新日 | 2024-01-10 | 実験手法 | X-RAY DIFFRACTION (1.47 Å) | 主引用文献 | Discovery of Novel Oral Protein Synthesis Inhibitors of Mycobacterium Tuberculosis that Target Leucyl-tRNA Synthetase. Antimicrob.Agents Chemother., 60, 2016
|
|
5AGR
| Crystal structure of the LeuRS editing domain of Mycobacterium tuberculosis in complex with the adduct (S)-3-(Aminomethyl)-7-ethoxybenzo[c][1,2]oxaborol-1(3H)-ol-AMP | 分子名称: | 1,2-ETHANEDIOL, 3-AMINOMETHYL-7-(ETHOXY)-3H-BENZO[C][1,2]OXABOROL-1-OL modified adenosine, LEUCINE, ... | 著者 | Palencia, A, Li, X, Alley, M.R.K, Ding, C, Easom, E.E, Hernandez, V, Meewan, M, Mohan, M, Rock, F.L, Franzblau, S.G, Wang, Y, Lenaerts, A.J, Parish, T, Cooper, C.B, Waters, M.G, Ma, Z, Mendoza, A, Barros, D, Cusack, S, Plattner, J.J. | 登録日 | 2015-02-03 | 公開日 | 2016-03-02 | 最終更新日 | 2024-01-10 | 実験手法 | X-RAY DIFFRACTION (1.3 Å) | 主引用文献 | Discovery of Novel Oral Protein Synthesis Inhibitors of Mycobacterium Tuberculosis that Target Leucyl-tRNA Synthetase. Antimicrob.Agents Chemother., 60, 2016
|
|
5LD8
| |
8VQR
| Crystal structure of chimeric SARS-CoV-2 RBD complexed with chimeric raccoon dog ACE2 | 分子名称: | 1,2-ETHANEDIOL, 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, ... | 著者 | Hsueh, F.-C, Shi, K, Aihara, H, Li, F. | 登録日 | 2024-01-19 | 公開日 | 2024-05-01 | 最終更新日 | 2024-11-06 | 実験手法 | X-RAY DIFFRACTION (2.565 Å) | 主引用文献 | Structural basis for raccoon dog receptor recognition by SARS-CoV-2 To Be Published
|
|
8UG9
| XBB.1.5 spike/Nb5 complex | 分子名称: | 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, Nanosota-5, ... | 著者 | Ye, G, Bu, F, Liu, B, Li, F. | 登録日 | 2023-10-05 | 公開日 | 2024-08-28 | 最終更新日 | 2024-09-25 | 実験手法 | ELECTRON MICROSCOPY (3.49 Å) | 主引用文献 | Dual-role epitope on SARS-CoV-2 spike enhances and neutralizes viral entry across different variants. Plos Pathog., 20, 2024
|
|
6AX2
| |
8G7A
| |
8G77
| SARS-CoV-2 spike/Nb6 complex | 分子名称: | 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, Nanosota-6, ... | 著者 | Ye, G, Bu, F, Liu, B, Li, F. | 登録日 | 2023-02-16 | 公開日 | 2024-02-21 | 最終更新日 | 2024-10-30 | 実験手法 | ELECTRON MICROSCOPY (2.8 Å) | 主引用文献 | Dual-role epitope on SARS-CoV-2 spike enhances and neutralizes viral entry across different variants. Plos Pathog., 20, 2024
|
|
8G71
| Spike/Nb2 complex with 1 RBD up | 分子名称: | 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, Spike glycoprotein | 著者 | Ye, G, Bu, F, Liu, B, Li, F. | 登録日 | 2023-02-16 | 公開日 | 2024-02-21 | 最終更新日 | 2024-10-09 | 実験手法 | ELECTRON MICROSCOPY (2.1 Å) | 主引用文献 | SARS-CoV-2 spike/Nb2 complex with 1 RBD up To Be Published
|
|
8G79
| |
8G7B
| |
8G75
| SARS-CoV-2 spike/Nb4 complex with 2 RBDs up and 3 Nb4 bound | 分子名称: | 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, Nanosota-4, ... | 著者 | Ye, G, Bu, F, Liu, B, Li, F. | 登録日 | 2023-02-16 | 公開日 | 2024-01-24 | 最終更新日 | 2024-10-30 | 実験手法 | ELECTRON MICROSCOPY (3.4 Å) | 主引用文献 | Discovery of Nanosota-2, -3, and -4 as super potent and broad-spectrum therapeutic nanobody candidates against COVID-19. J.Virol., 97, 2023
|
|
8G72
| SARS-CoV-2 spike/Nb2 complex with 1 RBD up (local refinement at 5.6 A) | 分子名称: | Nanosota-2, Spike glycoprotein | 著者 | Ye, G, Bu, F, Liu, B, Li, F. | 登録日 | 2023-02-16 | 公開日 | 2024-01-24 | 最終更新日 | 2024-10-16 | 実験手法 | ELECTRON MICROSCOPY (5.6 Å) | 主引用文献 | Discovery of Nanosota-2, -3, and -4 as super potent and broad-spectrum therapeutic nanobody candidates against COVID-19. J.Virol., 97, 2023
|
|
8G74
| SARS-CoV-2 spike/Nb3 complex with 1 RBD up and 2 Nb3 | 分子名称: | 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, Nanosota-3, ... | 著者 | Ye, G, Bu, F, Liu, B, Li, F. | 登録日 | 2023-02-16 | 公開日 | 2024-01-24 | 実験手法 | ELECTRON MICROSCOPY (2.5 Å) | 主引用文献 | Discovery of Nanosota-2, -3, and -4 as super potent and broad-spectrum therapeutic nanobody candidates against COVID-19. J.Virol., 97, 2023
|
|
8G73
| SARS-CoV-2 spike/Nb3 complex with 2 RBDs up and 3 Nb3 bound at 2.5 A | 分子名称: | 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, Nanosota-3, ... | 著者 | Ye, G, Bu, F, Liu, B, Li, F. | 登録日 | 2023-02-16 | 公開日 | 2024-01-24 | 最終更新日 | 2024-10-16 | 実験手法 | ELECTRON MICROSCOPY (2.5 Å) | 主引用文献 | Discovery of Nanosota-2, -3, and -4 as super potent and broad-spectrum therapeutic nanobody candidates against COVID-19. J.Virol., 97, 2023
|
|
8G78
| Local refinement of SARS-CoV-2 spike/nanobody mixture complex around NTD | 分子名称: | 2-acetamido-2-deoxy-beta-D-glucopyranose, Nanosota-5, Nanosota-6, ... | 著者 | Ye, G, Bu, F, Liu, B, Li, F. | 登録日 | 2023-02-16 | 公開日 | 2024-02-21 | 最終更新日 | 2024-10-30 | 実験手法 | ELECTRON MICROSCOPY (3.4 Å) | 主引用文献 | Local refinement of SARS-CoV-2 spike/nanobody mixture complex around NTD To Be Published
|
|
8G76
| SARS-CoV-2 spike/Nb5 complex | 分子名称: | 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, Nanosota-5, ... | 著者 | Ye, G, Bu, F, Liu, B, Li, F. | 登録日 | 2023-02-16 | 公開日 | 2024-02-21 | 最終更新日 | 2024-11-06 | 実験手法 | ELECTRON MICROSCOPY (3.8 Å) | 主引用文献 | Dual-role epitope on SARS-CoV-2 spike enhances and neutralizes viral entry across different variants. Plos Pathog., 20, 2024
|
|
8G7C
| |
8G70
| SARS-CoV-2 spike/nanobody mixture complex | 分子名称: | 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, Nanosota-3, ... | 著者 | Ye, G, Bu, F, Liu, B, Li, F. | 登録日 | 2023-02-16 | 公開日 | 2024-02-21 | 最終更新日 | 2024-10-23 | 実験手法 | ELECTRON MICROSCOPY (3.4 Å) | 主引用文献 | SARS-CoV-2 spike/nanobody mixture complex To Be Published
|
|